Hot off the press! The 4Q10 & 2010 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too!

The 2010 OnBioVC Trend Analysis tracked, in aggregate, 281 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $5,190.0M. Compared to 2009 OnBioVC data, this investment activity represents a decrease in the number of year-over-year financings by 71 (281 v. 352) and a decrease in year-over-year invested capital of $1,085.7.9M ($5,190.5M v. $6,662.9M).

Many thanks to our wonderful partners, please show them your support!

Apredica – Preclinical ADME Tox Contract Research
Colorado Bioscience Association – Advocacy. Representation. Service.
San Jose BioCenter – Giving emerging companies that Big Company Advantage…
Headwaters | MB – Independent middle market investment bank
Freestone Group – Integrated Solutions for Emerging Life Science
Lockton – Lifescience Industry Specific Insurance Needs
Regulus – A Full Spectrum of Regulatory Affairs and Quality Assurance Solutions
The Email MBA – Learn business skills in your inbox, at your own pace
CID4 – Accelerating the Colorado bioscience ecosystem
BioBeers – Where Great Minds Drink Alike…


Sign up [HERE] for FREE Subscriptions to ‘Pharmaceutical Executive’ and ‘Life Science Leader’ Magazines (and other journals too!)